People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...
It’s the first FDA approval for a pain medication in 25 years. How does the drug work, and who is it for?
Nerandomilast worked better than a placebo to preserve lung function in adults with progressive pulmonary fibrosis in a Phase ...
An expert discusses the current understanding of corticosteroids in managing pulmonary fibrosis and how it has evolved in ...
Patients with progressive pulmonary fibrosis who received nerandomilast showed improved forced vital capacity from baseline ...
The experts will assess unblinded data from BEACON-IPF to figure out why a data safety monitoring board recommended ...
U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results